In addition we observed no significant differences in the distribution of the high (AA), medium (AG) or low (GG) genotypes of TNF-α among the South African cervical cancer patients and healthy controls (and in the combined race groups) (X2 = 2.26) even when the data were adjusted for potential confounders (data not shown). This evidence concerns the gene TNF and cervical cancer.